From: Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
Variable | n = 16 (%) |
---|---|
Histological grade (Stanford) | |
Low | 8 (50%) |
High | 8 (50%) |
Histological grade (FNCLCC) | |
Low | 7 (44%) |
Intermediate | 3 (19%) |
High | 6 (37%) |
Hormone receptor status | |
ER | |
Moderate to strong (grade 2–3) | 13 (81%) |
Weak (grade 1) | 3 (19%) |
PgR | |
Moderate to strong (grade 2–3) | 10 (62.5%) |
Weak (grade 1) | 6 (37.5%) |
ER and PgR | |
Moderate to strong (grade 2–3) | 10 (62.5%) |
Weak (grade 1) | 2 (12.5%) |
% ER staining | |
>90% | 10 (62.5%) |
>50% | 14 (87.5%) |
10-50% | 1 (6.25%) |
Unknown | 1 (6.25%) |
% PgR staining | |
>90% | 6 (37.5%) |
>50% | 11 (68.75%) |
10-50% | 1 (6.25%) |
0% | 2 (12.5%) |
unknown | 2 (12.5%) |